Hashim Mir 4
4 · Rani Therapeutics Holdings, Inc. · Filed Mar 29, 2023
Insider Transaction Report
Form 4
Hashim Mir
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2023-03-27+139,000→ 273,265 total - Award
Stock Option (Right to Buy)
2023-03-27+205,800→ 205,800 totalExercise: $5.44Exp: 2033-03-26→ Class A Common Stock (205,800 underlying)
Footnotes (2)
- [F1]The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.
- [F2]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.